Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of B-lymphocytes in the lymph nodes, particularly affecting the axilla and upper limb. This condition can lead to significant morbidity due to lymphadenopathy and potential systemic symptoms. Accurate coding with ICD-10 Code C82.54 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code C82.54 represents diffuse follicle center lymphoma localized to the lymph nodes of the axilla and upper limb. This condition is a subtype of non-Hodgkin lymphoma, which arises from the abnormal proliferation of B-cells. The code should be used in clinical documentation and billing when a patient presents with symptoms indicative of this lymphoma, ensuring accurate representation of the patient's diagnosis for treatment and reimbursement purposes.
Diffuse follicle center lymphoma is a hematological malignancy that primarily affects the lymphatic system, leading to the enlargement of lymph nodes, particularly in the axillary and upper limb regions. The etiology is often linked to genetic mutations and environmental factors, and it can progress to more severe systemic involvement if left untreated. Prompt medical attention is crucial for effective management.
ICD-10 Code C82.54 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to diffuse follicle center lymphoma. This code is relevant in both acute and chronic care settings, facilitating comprehensive patient management and ensuring accurate billing for services rendered.
In SOAP notes, ICD-10 Code C82.54 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of diffuse follicle center lymphoma. This code is essential for ensuring continuity of care, supporting appropriate billing practices, and meeting EHR documentation standards.
Management of diffuse follicle center lymphoma often requires a multidisciplinary approach, including chemotherapy and supportive care. Hospitalization may be necessary for severe cases or complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C82.54 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 77014 | Radiologic examination, lymph nodes. |
Common Questions About Using ICD-10 Code C82.54 for Diffuse folicl center lymph, nodes of axilla and upper limb
What are the common symptoms of diffuse follicle center lymphoma?
Common symptoms include painless swelling of lymph nodes, unexplained weight loss, night sweats, and fatigue. Patients may also experience systemic symptoms as the disease progresses.
How is diffuse follicle center lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of lymphoma cells.
What treatment options are available for this condition?
Treatment often includes chemotherapy regimens such as R-CHOP, along with supportive care to manage symptoms and monitor for complications.
Is hospitalization necessary for patients with diffuse follicle center lymphoma?
Hospitalization may be required for patients experiencing severe symptoms, complications, or those undergoing intensive chemotherapy treatment.
Clinical Notes
SOAP notes
DAP notes
AI medical notes